Choosing Wisely: A Comparative Analysis of Generic and Branded Anti-Hypertensive Drugs Telmisartan And Metoprolol Succinate

Choosing Wisely: A Comparative Analysis of Generic and Branded Anti-Hypertensive Drugs Telmisartan And Metoprolol Succinate

Registration ID: IJNRD_222839

Published ID: IJNRD2405820

DOI: Click Here to Get

Saniya Dastagir Pathan , Shahin Mehboob Pathan , Dipti Vilas Sable , Swarup Manohar Harne , Dr. Wakale V.S.

Generic drug’s , Branded drug’s , Safety , Efficacy , Affordability , Cost of therapy for generic drug’s , health policy , Scope , Objectives and Definition , Methodology , etc.

High blood pressure, or hypertension, is a prevalent heart ailment that affects a large proportion of the world's population. High blood pressure medication is commonly used to treat the condition. Antihypertensive drugs are prescribed in medicine with both brand and generic names. The goal of this study is to compare generic and branded versions of two commonly prescribed antihypertensive drugs, telmisartan and metoprolol succinate, based on quality. This study considered a number of evaluation factors, including weight variation, weight uniformity, hardness, brittleness, disintegration, and dissolution. The use of brand-name or generic drugs has recently caused much debate on a global scale. Furthermore, the governments of a number of countries actively encourage the use of generic pharmaceuticals instead of name-brand medications. A generic drug has therapeutic efficacy similar to its brand-name counterpart and includes the same active ingredient or substances. Generic drugs are much less expensive than name-brand medications since they do not have to go through the extensive and costly preclinical or clinical trials that brand-name medications undertake, which significantly raises the cost of those prescriptions. This analysis provides an overview of the comparative effectiveness of metoprolol succinate and telmisartan generics versus name-brand drugs. The objective also attempts to draw attention to the discrepancies in prices between the two categories, as well as the laws and controls surrounding both pharmaceuticals.

Published Paper   E-Certificate

"Choosing Wisely: A Comparative Analysis of Generic and Branded Anti-Hypertensive Drugs Telmisartan And Metoprolol Succinate", IJNRD - INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (www.IJNRD.org), ISSN:2456-4184, Vol.9, Issue 5, page no.I177-I189, May 2024, Available :https://ijnrd.org/papers/IJNRD2405820.pdf

Volume 9 Issue 5, May-2024

Pages : I177-I189

Paper Reg. ID: IJNRD_222839

Published Paper Id: IJNRD2405820

Downloads: 000121206

Research Area: Pharmacy

Country: Pune, Maharashtra , India

Published Paper PDF: https://ijnrd.org/papers/IJNRD2405820.pdf

Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRD2405820

Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)

ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Publisher: IJNRD (IJ Publication) Janvi Wave

This work is licensed under a Creative Commons Attribution 4.0 International License and The Open Definition

Call For Paper - Volume 10 | Issue 8 | August 2025

IJNRD is Scholarly open access journals, Peer-reviewed, and Refereed Journals, High Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool), Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI) with Open-Access Publications.

INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to explore advances in research pertaining to applied, theoretical and experimental Technological studies. The goal is to promote scientific information interchange between researchers, developers, engineers, students, and practitioners working in and around the world. IJNRD will provide an opportunity for practitioners and educators of engineering field to exchange research evidence, models of best practice and innovative ideas.

Indexing In Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar | AI-Powered Research Tool, Microsoft Academic, Academia.edu, arXiv.org, Research Gate, CiteSeerX, ResearcherID Thomson Reuters, Mendeley : reference manager, DocStoc, ISSUU, Scribd, and many more

How to submit the paper?

Important Dates for Current issue

Paper Submission Open For: August 2025

Current Issue: Volume 10 | Issue 8

Last Date for Paper Submission: Till 31-Aug-2025

Notification of Review Result: Within 1-2 Days after Submitting paper.

Publication of Paper: Within 01-02 Days after Submititng documents.

Frequency: Monthly (12 issue Annually).

Journal Type: International Peer-reviewed, Refereed, and Open Access Journal.

Subject Category: Research Area